All news

Pfizer, Inc. (PFE) Stock Forecasts

Alpha Vantage · Yahoo! Finance Canada · · AI-summarised by FinFlash

Morningstar strategist Karen Andersen provides an analyst report on Pfizer Inc., maintaining a $32 fair value estimate. The report indicates strong growth in newer drugs is countering declines from COVID-related sales. Pfizer remains one of the largest pharmaceutical firms globally, with prescription drugs and vaccines forming the majority of its sales.

Read original source

PFE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.